Without knowing much all I can say is whoever buys CU6 be it...

Without knowing much all I can say is whoever buys CU6 be it insto or retail we want them to be sticky hands and not keep dumping on market or use it for loaning to shorters. If the company keeps delivering then the SP could keep trending higher.

There were many days we could buy around the CR price. I posted previously that may be the mgmt didn’t really pay too much attention to the retail SHs because it was an underwritten issue- so I agree with the sentiment. I had enough CU6 before the CR but despite the 1:33, I fully exercised it thinking it is directly contributing towards cancer research instead of buying on market at the same price.

Anyway, that’s all behind us now. We don’t expect to see another CR till early 2026 assuming we are around till then. But more importantly we want the BOD and the instos and SHs to hold strong for a great outcome as we do have best tailwinds one can hope for.

Just my own sentiments. DYOR.